Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex‐Dependent Manner

Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex‐Dependent Manner

Abstract Sex disparities in serum bile acid (BA) levels and Alzheimer's disease (AD) prevalence have been established. However, the precise link between changes in serum BAs and AD development remains elusive. Here, authors quantitatively determined 33 serum BAs and 58 BA features in 4 219 samp...

Full description

Bibliographic Details
Main Authors:	Tianlu Chen, Lu Wang, Guoxiang Xie, Bruce S. Kristal, Xiaojiao Zheng, Tao Sun, Matthias Arnold, Gregory Louie, Mengci Li, Lirong Wu, Siamak Mahmoudiandehkordi, Matthew J. Sniatynski, Kamil Borkowski, Qihao Guo, Junliang Kuang, Jieyi Wang, Kwangsik Nho, Zhenxing Ren, Alexandra Kueider‐Paisley, Colette Blach, Rima Kaddurah‐Daouk, Wei Jia, Alzheimer's Disease Neuroimaging Initiative (ADNI) and the Alzheimer Disease Metabolomics Consortium (ADMC)
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Series:	Advanced Science
Subjects:	alzheimer's disease bile acid cholesterol mild cognitive impairment sex difference
Online Access:	https://doi.org/10.1002/advs.202306576

Similar Items

Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
by: Dinesh Kumar Barupal, et al.
Published: (2019-12-01)

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers
by: Nho, K, et al.
Published: (2018)

Quick assessment for systematic test statistic inflation/deflation due to null model misspecifications in genome-wide environment interaction studies.
by: Masao Ueki, et al.
Published: (2019-01-01)

Revealing heterogeneity of brain imaging phenotypes in Alzheimer's disease based on unsupervised clustering of blood marker profiles.
by: Gerard Martí-Juan, et al.
Published: (2019-01-01)

Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease
by: Kamil Borkowski, et al.
Published: (2021-09-01)

Author Correction: Predicting Alzheimer’s disease progression using multi-modal deep learning approach
by: Garam Lee, et al.
Published: (2023-08-01)

Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers
by: Nho, K, et al.
Published: (2019)

Network propagation of rare variants in Alzheimer's disease reveals tissue-specific hub genes and communities.
by: Marzia Antonella Scelsi, et al.
Published: (2021-01-01)

Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease
by: Priyanka Baloni, et al.
Published: (2022-10-01)

Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
by: Ze Wang, et al.
Published: (2020-11-01)

Selection for depression-specific dementia cases with replication in two cohorts.
by: Donald R Royall, et al.
Published: (2019-01-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
by: Anna Rubinski, et al.
Published: (2020-10-01)

Longitudinal analysis of brain structure using existence probability
by: Norihide Maikusa, et al.
Published: (2020-12-01)

Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
by: Yurika Upadhyaya, et al.
Published: (2020-04-01)

Fused multi-modal similarity network as prior in guiding brain imaging genetic association
by: Bing He, et al.
Published: (2023-05-01)

Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease
by: Sepehr Golriz Khatami, et al.
Published: (2022-04-01)

Imputation-Based Variable Selection Method for Block-Wise Missing Data When Integrating Multiple Longitudinal Studies
by: Zhongzhe Ouyang, et al.
Published: (2024-03-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
by: Guanan Zhao, et al.
Published: (2024-01-01)

Identification of Disease-Related Genes That Are Common between Alzheimer’s and Cardiovascular Disease Using Blood Genome-Wide Transcriptome Analysis
by: Taesic Lee, et al.
Published: (2021-10-01)

A Novel Coupling Model of Physiological Degradation and Emotional State for Prediction of Alzheimer’s Disease Progression
by: Jiawei Yang, et al.
Published: (2022-08-01)

CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia.
by: Pan Fu, et al.
Published: (2022-01-01)

Fast score test with global null estimation regardless of missing genotypes.
by: Shuntaro Sato, et al.
Published: (2018-01-01)

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
by: Yeonwoo Chung, et al.
Published: (2021-07-01)

Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers.
by: Daoqiang Zhang, et al.
Published: (2012-01-01)

Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
by: Matthew Velazquez, et al.
Published: (2021-01-01)

Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy.
by: Edit Frankó, et al.
Published: (2013-01-01)

Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment
by: Jung-Min Pyun, et al.
Published: (2021-08-01)

Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles
by: Daniel A. Llano, et al.
Published: (2020-11-01)

Diagnosis of Alzheimer’s Disease via Multi-Modality 3D Convolutional Neural Network
by: Yechong Huang, et al.
Published: (2019-05-01)

Genome-Wide Association Analysis across Endophenotypes in Alzheimer’s Disease: Main Effects and Disease Stage-Specific Interactions
by: Thea J. Rosewood, et al.
Published: (2023-10-01)

ADataViewer: exploring semantically harmonized Alzheimer’s disease cohort datasets
by: Yasamin Salimi, et al.
Published: (2022-05-01)

Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s Disease
by: Laura Madrid, et al.
Published: (2021-12-01)

Hierarchical anatomical brain networks for MCI prediction: revisiting volumetric measures.
by: Luping Zhou, et al.
Published: (2011-01-01)

Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
by: Taeho Jo, et al.
Published: (2020-12-01)

Random forest prediction of Alzheimer's disease using pairwise selection from time series data
by: Moore, P, et al.
Published: (2019)

c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer’s disease
by: Sherlyn Jemimah, et al.
Published: (2023-10-01)

How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database
by: Stavros I Dimitriadis, et al.
Published: (2018-01-01)

A combination of 3-D discrete wavelet transform and 3-D local binary pattern for classification of mild cognitive impairment
by: Harsh Bhasin, et al.
Published: (2020-02-01)

Rare Variant Analysis and Molecular Dynamics Simulation in Alzheimer’s Disease Identifies Exonic Variants in FLG
by: Weixue Xiong, et al.
Published: (2022-05-01)

Dependency criterion based brain pathological age estimation of Alzheimer’s disease patients with MR scans
by: Yongming Li, et al.
Published: (2017-04-01)